New ultrasound technique could sharpen liver surgery decisions
NCT ID NCT01880554
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether using a contrast dye during ultrasound while operating on liver tumors from colorectal cancer helps surgeons make better decisions. 68 patients were enrolled, and doctors compared the surgical plan before and after the contrast-enhanced ultrasound. The goal was to see if the new imaging changed the surgery in a helpful way.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- contrast-enhanced intraoperative ultrasound (device)
- What this could lead to
- If successful, this could make liver surgery more precise by helping surgeons see tumors they might otherwise miss.
- What could go wrong
- This is a small, completed phase 2 study, so results need confirmation in larger trials. The technique may not improve outcomes for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASES FROM COLORECTAL PRIMARY CANCER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Bergonié
Bordeaux, Aquitaine, 33000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.